Follow this innovation
[ via 
] [?]
Genetic Test to Diagnose Dilated Cardiomyopathy (DCM)
Brigham and Women's Hospital
posted on 04/04/2012
Technology: The invention is a genetic test using a blood/saliva sample that interrogates the Titin gene for the presence of 72 novel mutations. The inventors have found that approximately 25% of all DCM patients have a truncating mutation in Titin that result in a truncated protein that is the molecular basis of DCM. Also, these mutations are shown to be inherited and have a penetrance of 95%. Patients identified having this mutation can monitor themselves for symptoms of the disease and/or may change their lifestyle for disease prevention. Applications: - Diagnosis of DCM in approximately 25% idiopathic DCM cases - Detection of mutations in 50% of first degree relatives of DCM patients Advantages: - Identify high risk patients for the mutation - Improve treatment options - Simple test - Better than current tests on the market
File Number: 21140
Other Information: *Investigator(s)*
Daniel Christine E.; Herman Jonathan G.; Seidman Seidman
*Contact*
Amita Joshi, 617-954-9526
This innovation currently is not available for online licensing. Please contact Mary Auge at Brigham and Women's Hospital for more information.
request more info
ProfileFind more innovations
